The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A novel peptide with a potential to enhance sorafenib’s therapeutic effects in hepatocellular carcinoma.
Joline Sijing Lim
No relevant relationships to disclose
Todor Dimitrov
No relevant relationships to disclose
Kol Jia Yong
No relevant relationships to disclose
Chong Gao
No relevant relationships to disclose
Daniel G Tenen
No relevant relationships to disclose
Li Chai
No relevant relationships to disclose